PortfoliosLab logoPortfoliosLab logo
KALV vs. AAOI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KALV vs. AAOI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KalVista Pharmaceuticals, Inc. (KALV) and Applied Optoelectronics, Inc. (AAOI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


KALV

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*

AAOI

1D
-6.70%
1M
-33.82%
6M
231.79%
YTD
220.94%
1Y
293.94%
3Y*
130.46%
5Y*
71.14%
10Y*
25.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KALV vs. AAOI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KALV
KalVista Pharmaceuticals, Inc.
67.18%90.67%-30.86%81.21%-48.90%-30.33%6.63%-9.82%102.56%37.91%
AAOI
Applied Optoelectronics, Inc.
220.94%-5.43%90.79%922.22%-63.23%-39.60%-28.37%-23.01%-59.20%61.35%

Correlation

The correlation between KALV and AAOI is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Apr 9, 2015

0.18

Fundamentals

Market Cap

KALV:

$1.36B

AAOI:

$8.98B

EPS

KALV:

-$3.18

AAOI:

-$0.62

PS Ratio

KALV:

18.94

AAOI:

15.42

Total Revenue (TTM)

KALV:

$73.62M

AAOI:

$507.00M

Gross Profit (TTM)

KALV:

$67.54M

AAOI:

$150.29M

EBITDA (TTM)

KALV:

-$170.39M

AAOI:

-$26.44M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KALV vs. AAOI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KALV

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


AAOI
AAOI Risk / Return Rank: 9292
Overall Rank
AAOI Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
AAOI Sortino Ratio Rank: 9191
Sortino Ratio Rank
AAOI Omega Ratio Rank: 8787
Omega Ratio Rank
AAOI Calmar Ratio Rank: 9696
Calmar Ratio Rank
AAOI Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KALV vs. AAOI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KalVista Pharmaceuticals, Inc. (KALV) and Applied Optoelectronics, Inc. (AAOI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KALVAAOIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.33

Calmar ratioReturn relative to maximum drawdown

5.94

Martin ratioReturn relative to average drawdown

14.74

KALV vs. AAOI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

KALV vs. AAOI - Drawdown Comparison


Loading charts...

Drawdown Indicators


KALVAAOIDifference

Max Drawdown

Largest peak-to-trough decline

-98.49%

Max Drawdown (1Y)

Largest decline over 1 year

-49.85%

Max Drawdown (3Y)

Largest decline over 3 years

-77.17%

Max Drawdown (5Y)

Largest decline over 5 years

-82.64%

Max Drawdown (10Y)

Largest decline over 10 years

-98.49%

Current Drawdown

Current decline from peak

-49.85%

Average Drawdown

Average peak-to-trough decline

-65.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.05%

Volatility

KALV vs. AAOI - Volatility Comparison


Loading charts...

Volatility by Period


KALVAAOIDifference

Volatility (1M)

Calculated over the trailing 1-month period

32.43%

Volatility (6M)

Calculated over the trailing 6-month period

107.89%

Volatility (1Y)

Calculated over the trailing 1-year period

139.62%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

120.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.70%

Dividends

KALV vs. AAOI - Dividend Comparison

Neither KALV nor AAOI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KALV vs. AAOI - Financials Comparison

This section allows you to compare key financial metrics between KalVista Pharmaceuticals, Inc. and Applied Optoelectronics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
59.93M
151.14M
(KALV) Total Revenue
(AAOI) Total Revenue
Values in USD except per share items

KALV vs. AAOI - Profitability Comparison

The chart below illustrates the profitability comparison between KalVista Pharmaceuticals, Inc. and Applied Optoelectronics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
90.4%
29.1%
Portfolio components
KALV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, KalVista Pharmaceuticals, Inc. reported a gross profit of 54.15M and revenue of 59.93M. Therefore, the gross margin over that period was 90.4%.

AAOI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Applied Optoelectronics, Inc. reported a gross profit of 43.92M and revenue of 151.14M. Therefore, the gross margin over that period was 29.1%.

KALV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, KalVista Pharmaceuticals, Inc. reported an operating income of -13.31M and revenue of 59.93M, resulting in an operating margin of -22.2%.

AAOI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Applied Optoelectronics, Inc. reported an operating income of -12.99M and revenue of 151.14M, resulting in an operating margin of -8.6%.

KALV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, KalVista Pharmaceuticals, Inc. reported a net income of -5.37M and revenue of 59.93M, resulting in a net margin of -9.0%.

AAOI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Applied Optoelectronics, Inc. reported a net income of -14.28M and revenue of 151.14M, resulting in a net margin of -9.5%.


Frequently Asked Questions


KALV and AAOI have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for KALV and AAOI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer